A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency.

Steroidogenic factor 1 (SF-1) is an orphan nuclear receptor that plays key roles in endocrine development and function. Knockout mice lacking SF-1 have adrenal and gonadal agenesis, impaired gonadotropin expression, and structural abnormalities of the ventromedial hypothalamic nucleus. Previous studies have identified three human subjects with mutations in SF-1 causing adrenocortical insufficiency with varying degrees of gonadal dysfunction. We now describe a novel 8-bp microdeletion of SF-1, isolated from a 46, XY patient who presented with gonadal agenesis but normal adrenal function, which causes premature termination upstream of sequences encoding the activation function 2 domain. In cell transfection experiments, the mutated protein possessed no intrinsic transcriptional activity but rather inhibited the function of the wild-type protein in most cell types. To our knowledge, this is the first example of an apparent dominant-negative effect of a SF-1 mutation in humans. These findings, which define a SF-1 mutation that apparently differentially affects its transcriptional activity in vivo in the adrenal cortex and the gonads, may be relevant to the cohort of patients who present with 46, XY sex reversal but normal adrenal function.

[1]  K. Parker,et al.  A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation , 1994, Cell.

[2]  David I. Wilson,et al.  Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. , 2001, Molecular endocrinology.

[3]  J. Jameson,et al.  Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. , 2002, The Journal of clinical endocrinology and metabolism.

[4]  K. Parker,et al.  Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. , 1992, Molecular endocrinology.

[5]  A. Steinmetz,et al.  Binding of ligands and activation of transcription by nuclear receptors. , 2001, Annual review of biophysics and biomolecular structure.

[6]  G. Hammer,et al.  Wilms' Tumor 1 and Dax-1 Modulate the Orphan Nuclear Receptor SF-1 in Sex-Specific Gene Expression , 1998, Cell.

[7]  J. Lund,et al.  Mutations in the Activation Function-2 Core Domain of Steroidogenic Factor-1 Dominantly Suppresses PKA-dependent Transactivation of the Bovine CYP17 Gene* , 1998, The Journal of Biological Chemistry.

[8]  J. McGarry,et al.  Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. , 2002, Endocrinology.

[9]  M. Ito,et al.  Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. , 1998, Molecular endocrinology.

[10]  B. B. Mendonça,et al.  Management of ambiguous genitalia in pseudohermaphrodites: new perspectives on vaginal dilation. , 1997, Fertility and sterility.

[11]  Y. Sadovsky,et al.  The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1. , 1997, Molecular endocrinology.

[12]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[13]  P. Val,et al.  SF-1 a key player in the development and differentiation of steroidogenic tissues , 2003, Nuclear receptor.

[14]  G. Abraham Radioimmunoassay of steroids in biological materials. , 1974 .

[15]  P. Hindmarsh,et al.  A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans , 1999, Nature Genetics.

[16]  S. Honda,et al.  Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. , 1993, The Journal of biological chemistry.

[17]  J. Milbrandt,et al.  Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Vass,et al.  A novel missense mutation (S18N) in the 5′ non-HMG box region of the SRY gene in a patient with partial gonadal dysgenesis and his normal male relatives , 1998, Human Genetics.

[19]  A. Schedl,et al.  Gene interactions in gonadal development. , 1999, Annual review of physiology.

[20]  J. Milbrandt,et al.  Nuclear Receptor DAX-1 Recruits Nuclear Receptor Corepressor N-CoR to Steroidogenic Factor 1 , 1998, Molecular and Cellular Biology.

[21]  K. Parker,et al.  A shared promoter element regulates the expression of three steroidogenic enzymes. , 1991, Molecular endocrinology.

[22]  G. Chrousos,et al.  Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. , 1996, Journal of molecular endocrinology.

[23]  E. Schoenle,et al.  Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. , 2000, American journal of human genetics.

[24]  I. Arnhold,et al.  Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty. , 1987, Journal of steroid biochemistry.

[25]  K. Morohashi Gonadal and Extragonadal Functions of Ad4BP/SF-1: Developmental Aspects , 1999, Trends in Endocrinology & Metabolism.